Elutia Inc.

ELUT Healthcare Medical Devices

In the quarter to June 2026, revenue fell 11.7%, EPS grew 26.1% and free cash flow fell 2.52%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.79 0.00 0.00%
Market cap
$34.9M
P/E
0.6×
Fwd P/E
−1.7×
Dividend yield
—
F-score
5/9
Altman Z
−4.10
Beneish M
0.81
Dividend safety
n/a

Elutia Inc. (ELUT) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Elutia Inc. (ELUT) trades at a P/E ratio of 0.6×. Over the past ten years it has ranged from 0.0× (December 2025) to 1.0× (May 2026); the current reading is higher than 88% of that period. That is below the Medical Devices industry median of 23.2× and below the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.6× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 0.8× (11.22%)
Mar 2026 0.9× 61.26%
Dec 2025 0.6× —
Sep 2025 0.0× —
22 more quarters

Against its own ten years

Low 0.0× High 1.0×
Ten-year median 0.0×
Current reading's percentile 88

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on ELUT